Nicoleta Tohanean
Overview
Explore the profile of Nicoleta Tohanean including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barsan I, Ilut S, Tohanean N, Pop R, Vesa S, Perju-Dumbrava L
Medicina (Kaunas)
. 2024 Sep;
60(9).
PMID: 39336454
: Acute ischemic stroke (AIS) is a leading cause of death and disability with poor long-term outcomes. Creating a predictive score for long-term mortality in AIS might be important for...
2.
Barsan I, Ilut S, Tohanean N, Pop R, Vesa S, Perju-Dumbrava L
J Clin Med
. 2024 Aug;
13(16).
PMID: 39201031
: Understanding the prognostic factors of acute ischemic stroke (AIS) is essential for improving patient outcomes. The aim of this study was to establish the predictive role of plasmatic resistin...
3.
Tohanean N, Tucan P, Vanta O, Abrudan C, Pintea S, Gherman B, et al.
J Clin Med
. 2023 Jan;
12(2).
PMID: 36675354
The research aimed to evaluate the efficacy of the NeuroAssist, a parallel robotic system comprised of three robotic modules equipped with human-robot interaction capabilities, an internal sensor system for torque...
4.
Paval D, Cimpan C, Gherghel N, Damian L, Tohanean N, Miclutia I
Front Psychiatry
. 2022 Jun;
13:905088.
PMID: 35722579
The majority of patients with anti-N-Methyl-D-Aspartate receptor (NMDAR) encephalitis present with psychiatric symptoms and subsequently develop neurological features. However, isolated psychiatric episodes occur in <5% of affected individuals, less frequent...
5.
Perju-Dumbrava L, Barsan M, Leucuta D, Popa L, Pop C, Tohanean N, et al.
Exp Ther Med
. 2022 Jan;
23(2):153.
PMID: 35069834
Parkinson's disease (PD) is the second most frequent neurodegenerative disorder following Alzheimer's disease. Advanced stages of PD, 4 or 5 of the Hoehn and Yahr Scale, are characterized by severe...
6.
Popa L, Leucuta D, Tohanean N, Popa S, Perju-Dumbrava L
Medicine (Baltimore)
. 2020 Nov;
99(46):e23249.
PMID: 33181715
Levodopa-carbidopa intestinal gel (LCIG) is a method of continuous administration of levodopa - the standard treatment in Parkinson disease (PD, a neurodegenerative disorder characterized by resting tremor, rigidity, gait impairment,...
7.
Vanta O, Tohanean N, Pintea S, Perju-Dumbrava L
J Clin Med
. 2019 Sep;
8(10).
PMID: 31554346
(1) Background: Increased attention has lately been given to polyneuropathy in Parkinson's Disease (PD). Several papers postulated that large-fiber neuropathy (PNP) in PD is related to vitamin B12 deficiency and...
8.
Alexescu T, Cozma A, Sitar-Taut A, Negrean V, Handru M, Motocu M, et al.
Rom J Intern Med
. 2016 Sep;
54(3):161-172.
PMID: 27658164
Background: Obesity and overweight are two pathologies that are more and more frequent in the XXIst century diagnosis and are causing high morbidity and mortality rates in the general population,...